Our Story
“Born from billions of data points using AI and in collaboration with world-class cancer researchers”
Starlight Therapeutic is a precision oncology company focused solely on CNS (central nervous system) cancers, primarily brain cancers, which comprise a large and growing market globally.
It is estimated that there are over 120 subtypes of CNS cancers that have a devastating impact on adult and pediatric populations. Most of these CNS cancers do not have effective therapies and current treatment relies on a combination of surgery, radiotherapy, and chemotherapy. There is a significant need for new therapeutic options to improve patient outcomes. Starlight is developing our lead drug candidate, known as STAR-001, for some of the most unaddressed brain cancers.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
